Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: mokelumne river who wrote (1598)	12/30/2015 6:28:21 PM
From: eico20	Read Replies (1) \| Respond to of 2026

the launches are very small, the cold temp product seems more like a sampling , testing program, England has been selling a while, Sweden too, pasoce said the numbers won't come in until 2016-17, he knows something we don't perhaps, that the partners are NOT making a big commitment till the RTD comes out, seems to me they are just testing the approach with cold temp, pascoe said the sales are better by approaching all candidates vs just the severe cases, a USA launch should develop alot faster than the EU

To: mokelumne river who wrote (1598)	12/30/2015 7:28:41 PM
From: phoenix_rising	Read Replies (1) \| Respond to of 2026

I couldn't help myself and bought some more at 0.99 last night. Back to a nice round number of shares again which suits my OCD. All this chat about buy outs would be fantastic, but I do wonder if it is more than wishful thinking. We will see perhaps when the Fis results come out. I suspect rather than the company in discussions to be bought, that they are just gambling on a big spike to the PPS on excellent Fis results. I do hope I am wrong as that is too much of a gamble.